Related Experiment Video
Updated: May 29, 2026
An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
Published on: January 13, 2023
Photodynamic therapy as adjunctive therapy for morpheaform basal cell carcinoma
T Torres1, I Fernandes, V Costa
1Department of Dermatology, Centro Hospitalar do Porto - Hospital de Santo António, Edifício das Consultas Externas do Hospital Geral Santo António, Ex CICAP, 4100 Porto, Portugal. tiagotorres2002@hotmail.com
Abstract:
The authors decided to evaluate the possible use of methyl-aminolevulinate photodynamic therapy (MAL-PDT) as adjunctive therapy for morpheaform basal cell carcinoma prior to standard surgical excision in order to reduce tumor size and volume and to facilitate surgical treatment. It was observed that MAL-PDT may be an option as an adjunctive therapy prior to standard surgical excision of morpheaform basal cell carcinoma, leading to less invasive surgery.
